Our areas of focus

Building on King’s Health Partners Neurosciences’ current strengths, our programme is designed to accelerate innovation to further improve outcomes for patients.

A world-leading centre for neurological recovery 

NeurosciencesWe are developing neurological recovery knowledge, skills and ethos to drive improved pathways of care, outcomes and quality of life for patients.

This includes:

  • empowering patients to live as well as possible with their condition
  • enhancing patient pathways to maximise recovery 
  • harnessing the potential of emerging non-invasive techniques, assessing the effectiveness of interventions and further tailoring and personalising their therapeutic input
  • using novel technology to drive and improve recovery, eg transcranial magnetic stimulation, gaming consoles, robots and virtual wards 
  • extending the application of wearable technology to monitor patients at home and in the community, to support long-term treatment effectiveness 
  • measuring holistic outcomes across patient pathways beyond hospital-based care, including social and vocational outcomes. 

Learn about how we are improving Functional Neurological Disorder pathways.

A world-leading centre for experimental medicine

We are well positioned to lead the world in experimental patient studies. We have a high volume of excellent research, a large basic science enterprise, an exceptional infrastructure and a world leading bioengineering department in King’s College London.

We focus on the following areas:

Developing and trialling new therapies

In addition to developing new small-molecule drugs, we are developing gene therapy and cell therapies for diseases that are impossible to treat using conventional drug approaches.

Improving brain function through neuromodulation

Neuromodulation (electrical stimulation treatment) allows brain treatment to be delivered in the right part of the brain and potentially to specific time periods, without affecting other brain regions.

Biomarker discovery

Biomarkers are measurements of specific processes in the body that indicate activity of a disease and can be used to monitor response to treatment or predict response.

We are particularly working to develop biomarkers based on brain scans, gene function and electrical measurements of brain and nerve activity, such as Electroencephalography (EEG), Electromyography (EMG), and Nerve Conduction Studies (NCS).

Bringing engineering advances to treat neurological conditions

We are working with engineering colleagues to develop robotic systems and visualisation systems to improve neurosurgery and to bring artificial intelligence into real-time therapeutic decision-making.

Learn about Professor Ammar Al-Chalabi’s work in gene discovery.

A leading centre for education and training

We will build on our existing education and training strength to ensure that we continue to support the needs of our wider workforce.

Our areas of focus include:

  • developing clinical leadership skills
  • developing a pipeline of clinical research talent amongst our medics, nurses and allied health professionals
  • developing new ways to share our skills and expertise outside of our Institute, including online resources on the King’s Health Partners Learning Hub
  • developing resources to support improved models of care, including patient self-care. 

Driving innovation through digital and data science

We are pioneering the use of data science to transform outcomes for patients.

We are using CogStack, a clinical analytics platform which links rich sources of patient data held in multiple information systems at King’s College Hospital NHS Foundation Trust, to assist with real time patient management, predictive modelling, audit and research. CogStack features in a report published by NHSX, ‘Artificial Intelligence: How to get it right’.

We are also using digital technology and apps to transform the way in which we deliver care. Learn more about an app developed to help people with Parkinson’s disease manage their condition.

Mind & Body

Neurological conditions relate to the brain and nervous system and therefore the interaction between neurological (physical) needs and neuropsychological needs is complex.  They encompass cognitive, emotional, behavioural and social needs. Providing accurate diagnosis and effective treatment for these needs can be challenging.

The Neurological Alliance’s 2018/19 Patient Experience Survey shows that nationally mental health needs are still not well met. 30% of respondents who said they had mental health needs had not been referred or signposted to mental health support yet stated that they would have liked to have been provided with this option.

We want to be at the forefront in addressing patient needs holistically, building on our unique expertise and established integrated services in stroke and neurorehabilitation.

We are focused on enhancing the assessment, diagnosis and management of the emotional, cognitive and mental health needs of our patients, both through research and innovation in clinical practice.

Driving innovation across the local health care system and beyond

We are working in partnership with the South London Neurosciences Operational Delivery Network, the first of its kind in neurosciences in England, to drive improved care for patients across south London and beyond.